Page last updated: 2024-08-24

epigallocatechin gallate and Memory Disorders

epigallocatechin gallate has been researched along with Memory Disorders in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (10.53)29.6817
2010's14 (73.68)24.3611
2020's3 (15.79)2.80

Authors

AuthorsStudies
Auladell, C; Beas-Zarate, C; Busquets, O; Camins, A; Cano, A; Castro-Torres, RD; Ettcheto, M; Folch, J; García, ML; Manzine, PR; Olloquequi, J; Verdaguer, E1
Allahtavakoli, M; Fatemi, I; Hassanshahi, J; Kaeidi, A; Rahmani, M; Saffar, S; Sahamsizadeh, A; Sheibani, V1
Fan, J; Nan, S; Wang, P; Zhang, Y1
Chen, Y; Guo, Y; Nan, Y; Wang, S; Wang, X; Zhao, Y1
Fan, R; Gao, Y; Liu, X; Mi, Y; Qi, G; Qiao, Q; Sun, Y1
Aoyama, B; Kawano, T; Locatelli, FM; Nishigaki, A; Shigematsu-Locatelli, M; Tateiwa, H; Yamanaka, D; Yokoyama, M1
Albericio, G; Borralleras, C; Bosch-Morató, M; Campuzano, V; Guivernau, B; Muñoz, FJ; Ortiz-Romero, P; Pérez-Jurado, LA1
Aggarwal, R; Chakrabarti, A; Kaur, H; Kumar, B; Medhi, B; Modi, M; Radotra, BD; Sinha, VR1
Ding, L; Gao, X; Hu, J; Yu, S1
Andrade, JP; Assunção, M; Cardoso, A; Carvalho, F; Lukoyanov, N; Rodrigues, J1
Cao, YP; Han, K; Jia, N; Kong, JJ; Ren, GR; Sha, S; Zhang, XM1
Chen, F; He, M; Liu, H; Liu, M; Sha, L; Sha, X; Tao, L; Wang, S; Wei, M; Yao, L; Yao, Z; Zhang, Z; Zheng, Z; Zhu, Z1
Chang, KC; Fang, HW; Soung, HS; Tseng, HC; Wang, MH1
Chang, KC; Chen, CN; Lin, RF; Shih, RL; Soung, HS; Tsai, CC; Tseng, HC; Wang, MH1
Ha, TY; Hong, JT; Lee, JW; Lee, SY; Lee, YK; Oh, KW; Yuk, DY; Yun, YP1
Kumar, A; Kumar, P1
Baluchnejadmojarad, T; Roghani, M1
Choi, DY; Han, SB; Hong, JT; Lee, YJ; Oh, KW; Yun, YP1
Chang, KC; Chang, WJ; Soung, HS; Wang, MH1

Other Studies

19 other study(ies) available for epigallocatechin gallate and Memory Disorders

ArticleYear
Epigallocatechin-3-Gallate (EGCG) Improves Cognitive Deficits Aggravated by an Obesogenic Diet Through Modulation of Unfolded Protein Response in APPswe/PS1dE9 Mice.
    Molecular neurobiology, 2020, Volume: 57, Issue:4

    Topics: Amyloid beta-Peptides; Animals; Blood Glucose; Catechin; Cognitive Dysfunction; Diet, High-Fat; Hippocampus; Insulin; Liver; Male; Memory Disorders; Mice, Inbred C57BL; Mice, Obese; Mice, Transgenic; Models, Biological; Presenilin-1; Signal Transduction; Spatial Learning; Tissue Distribution; Unfolded Protein Response

2020
The effect of epigallocatechin-3-gallate on morphine-induced memory impairments in rat: EGCG effects on morphine neurotoxicity.
    Human & experimental toxicology, 2020, Volume: 39, Issue:7

    Topics: Animals; Apoptosis; Catechin; Glutathione Peroxidase; Hippocampus; Male; Malondialdehyde; Maze Learning; Memory; Memory Disorders; Morphine; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; Rats, Wistar; Superoxide Dismutase

2020
Epigallocatechin-3-Gallate Provides Protection Against Alzheimer's Disease-Induced Learning and Memory Impairments in Rats.
    Drug design, development and therapy, 2021, Volume: 15

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Antioxidants; Aspartic Acid Endopeptidases; Catechin; Cognition Disorders; Dose-Response Relationship, Drug; Hippocampus; Male; Maze Learning; Memory Disorders; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Sprague-Dawley; Spatial Memory; tau Proteins

2021
(-)-Epigallocatechin-3-gallate ameliorates memory impairment and rescues the abnormal synaptic protein levels in the frontal cortex and hippocampus in a mouse model of Alzheimer's disease.
    Neuroreport, 2017, Jul-05, Volume: 28, Issue:10

    Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Catechin; Disease Models, Animal; Disks Large Homolog 4 Protein; Frontal Lobe; Hippocampus; Maze Learning; Memory Disorders; Mice; Motor Activity; Neuroprotective Agents; Nootropic Agents; Peptide Fragments; Phosphorylation; Random Allocation; Spatial Memory; Synaptophysin; tau Proteins

2017
EGCG ameliorates high-fat- and high-fructose-induced cognitive defects by regulating the IRS/AKT and ERK/CREB/BDNF signaling pathways in the CNS.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2017, Volume: 31, Issue:11

    Topics: Animals; Brain-Derived Neurotrophic Factor; Catechin; Cell Line; Cyclic AMP Response Element-Binding Protein; Dietary Carbohydrates; Dietary Fats; Extracellular Signal-Regulated MAP Kinases; Fructose; Insulin Receptor Substrate Proteins; Learning Disabilities; MAP Kinase Signaling System; Memory Disorders; Mice; Proto-Oncogene Proteins c-akt

2017
Effects of epigallocatechin-3-gallate on systemic inflammation-induced cognitive dysfunction in aged rats.
    Journal of anesthesia, 2017, Volume: 31, Issue:5

    Topics: Animals; Aspartate Aminotransferases; Catechin; Cognitive Dysfunction; Cytokines; Hippocampus; Inflammation; Lipopolysaccharides; Male; Memory Disorders; Microglia; Rats; Rats, Sprague-Dawley; Sepsis

2017
Epigallocatechin-3-gallate improves cardiac hypertrophy and short-term memory deficits in a Williams-Beuren syndrome mouse model.
    PloS one, 2018, Volume: 13, Issue:3

    Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Memory Disorders; Memory, Short-Term; Mice; Mice, Mutant Strains; Williams Syndrome

2018
A New Therapeutic Approach for Brain Delivery of Epigallocatechin Gallate: Development and Characterization Studies.
    Current drug delivery, 2019, Volume: 16, Issue:1

    Topics: Animals; Behavior, Animal; Biological Availability; Blood-Brain Barrier; Catechin; Cerebral Infarction; Disease Models, Animal; Drug Compounding; Drug Liberation; Emulsions; Humans; Lipids; Male; Memory Disorders; Mice; Nanoparticles; Neuroprotective Agents; Treatment Outcome

2019
(‑)Epigallocatechin‑3‑gallate attenuates anesthesia‑induced memory deficit in young mice via modulation of nitric oxide expression.
    Molecular medicine reports, 2018, Volume: 18, Issue:6

    Topics: Anesthesia; Animals; Antioxidants; Apoptosis; Arginine; Biomarkers; Catechin; Disease Models, Animal; Indazoles; Male; Memory; Memory Disorders; Mice; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase Type I; Oxidative Stress

2018
Protective effects of a catechin-rich extract on the hippocampal formation and spatial memory in aging rats.
    Behavioural brain research, 2013, Jun-01, Volume: 246

    Topics: Age Factors; Animals; Catechin; Dendrites; Disease Models, Animal; Hippocampus; Lysosomes; Male; Malondialdehyde; Maze Learning; Memory Disorders; Microscopy, Electron, Transmission; Mitochondria; Neuroprotective Agents; Protein Carbonylation; Pyramidal Cells; Random Allocation; Rats; Rats, Wistar; Silver Staining; Space Perception

2013
(-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus.
    Molecular and cellular biochemistry, 2013, Volume: 380, Issue:1-2

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Blotting, Western; Catechin; Disease Models, Animal; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Immunohistochemistry; Insulin Receptor Substrate Proteins; JNK Mitogen-Activated Protein Kinases; Maze Learning; Memory Disorders; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments; Phosphorylation; Presenilin-1; Proto-Oncogene Proteins c-akt; Serine; Signal Transduction; Tumor Necrosis Factor-alpha

2013
(-)-Epigallocatechin-3-gallate ameliorates learning and memory deficits by adjusting the balance of TrkA/p75NTR signaling in APP/PS1 transgenic mice.
    Molecular neurobiology, 2014, Volume: 49, Issue:3

    Topics: Amyloid beta-Protein Precursor; Animals; Avoidance Learning; Catechin; Male; Memory Disorders; Mice; Mice, Transgenic; Presenilin-1; Receptor, trkA; Receptors, Nerve Growth Factor; Signal Transduction

2014
(-)Epigallocatechin-3-gallate decreases the stress-induced impairment of learning and memory in rats.
    Neuroscience letters, 2015, Aug-18, Volume: 602

    Topics: Animals; Antioxidants; Catechin; Hippocampus; Learning Disabilities; Male; Maze Learning; Memory Disorders; Motor Activity; Rats, Sprague-Dawley; Reactive Oxygen Species; Restraint, Physical; Spatial Learning; Stress, Psychological; Thiobarbituric Acid Reactive Substances

2015
Nitric oxide pathway activity modulation alters the protective effects of (-)Epigallocatechin-3-gallate on reserpine-induced impairment in rats.
    Behavioural brain research, 2016, May-15, Volume: 305

    Topics: Animals; Arginine; Catechin; Discrimination, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Exploratory Behavior; Glutathione; Hippocampus; Lipid Peroxidation; Male; Memory Disorders; Neuroprotective Agents; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Reserpine; Signal Transduction; Smell; Superoxide Dismutase

2016
(-)-Epigallocatechin-3-gallate prevents lipopolysaccharide-induced elevation of beta-amyloid generation and memory deficiency.
    Brain research, 2009, Jan-23, Volume: 1250

    Topics: Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Apoptosis; Avoidance Learning; Brain; Catechin; Cerebral Cortex; Cyclooxygenase 2; Glial Fibrillary Acidic Protein; Hippocampus; Lipopolysaccharides; Male; Maze Learning; Memory; Memory Disorders; Mice; Nerve Tissue Proteins; Neurons; Nitric Oxide Synthase Type II; Peptide Fragments

2009
Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2009, Volume: 47, Issue:10

    Topics: Animals; Brain; Carotenoids; Catechin; Disease Models, Animal; Glutathione; Huntington Disease; Lycopene; Male; Maze Learning; Memory Disorders; Neuroprotective Agents; Nitric Oxide; Oxidative Stress; Rats

2009
Chronic epigallocatechin-3-gallate ameliorates learning and memory deficits in diabetic rats via modulation of nitric oxide and oxidative stress.
    Behavioural brain research, 2011, Oct-31, Volume: 224, Issue:2

    Topics: Animals; Avoidance Learning; Blood Glucose; Body Weight; Catechin; Diabetes Mellitus, Experimental; Hippocampus; Indazoles; Learning Disabilities; Male; Malondialdehyde; Maze Learning; Memory Disorders; Nerve Tissue Proteins; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type I; Nitrites; Oxidative Stress; Rats; Rats, Wistar

2011
Epigallocatechin-3-gallate prevents systemic inflammation-induced memory deficiency and amyloidogenesis via its anti-neuroinflammatory properties.
    The Journal of nutritional biochemistry, 2013, Volume: 24, Issue:1

    Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Behavior, Animal; Catechin; Cells, Cultured; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Inflammation; Lipopolysaccharides; Male; Memory Disorders; Mice; Mice, Inbred ICR; Neurons; Nitric Oxide Synthase Type II; Peptide Fragments; Rats

2013
(-)-Epigallocatechin-3-gallate decreases the impairment in learning and memory in spontaneous hypertension rats.
    Behavioural pharmacology, 2012, Volume: 23, Issue:8

    Topics: Animals; Antioxidants; Blood Pressure; Catechin; Hippocampus; Hypertension; Learning Disabilities; Lipid Peroxidation; Male; Maze Learning; Memory Disorders; Motor Activity; Oxidative Stress; Rats; Rats, Inbred SHR; Reactive Oxygen Species; Tea

2012